View:
FORM 6-K/B SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month of July 2002 001-14832 (COMMISSION FILE NUMBER) - ------------------------------------------------------------------------------- CELESTICA INC. (TRANSLATION OF REGISTRANT'S NAME INTO ENGLISH) - ------------------------------------------------------------------------------- 12 CONCORDE PLACE TORONTO, ONTARIO CANADA, M3C 3R8 (416) 448-5800 (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F X Form 40-F ______ ----- Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ____ Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____ Indicate by check mark whether by furnishing the information contained in this Form, is the registrant also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes _____ No X ----- If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-_________ - ------------------------------------------------------------------------------- CELESTICA INC. FORM 6-K/B MONTH OF JULY 2002 Filed with this Form 6-K is the following: o Press release, dated July 29, 2002, the text of which is attached hereto as Exhibit 99.1 and is incorporated herein by reference. EXHIBITS 99.1 - Press Release, dated July 29, 2002 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. CELESTICA INC. Date: July 30, 2002 BY: /s/ Elizabeth L. DelBianco ----------------------------------- Elizabeth L. DelBianco Vice President & General Counsel EXHIBIT INDEX ------------- 99.1 - Press Release, dated July 29, 2002
Exhibit 99.1 FOR IMMEDIATE RELEASE MONDAY, JULY 29, 2002 CELESTICA RECEIVES TORONTO STOCK EXCHANGE APPROVAL FOR NORMAL COURSE ISSUER BID TORONTO, Canada -- Celestica Inc. (NYSE, TSX: CLS), a world leader in electronics manufacturing services (EMS), today announced that it has received approval from the Toronto Stock Exchange for its normal course issuer bid. The issuer bid, previously announced on July 17, 2002, is effective for a 12-month period effective August 1, 2002 and ending July 31, 2003. During that period the company is authorized to repurchase, at its discretion, up to 9,565,982 Subordinate Voting Shares, which is 5 per cent of the company's Subordinate Voting Shares on the open market subject to the normal terms and limitations of such bids. Any shares purchased pursuant to the bid will be purchased at the market price of the shares at the time of purchase and will be cancelled. The shares will be purchased on behalf of the Corporation by a registered investment dealer through the facilities of the New York or Toronto Stock Exchange. The funding for any purchase of will be financed out of the companies cash resources. At July 26, 2002, the company had approximately 191 million subordinate voting shares outstanding. The Corporation believes that its Subordinate Voting Shares have been trading in price ranges which may not fully reflect the value of such Subordinate Voting Shares. As a result, the Corporation believes that its outstanding Subordinate Voting Shares represent an attractive investment to the Corporation. ABOUT CELESTICA Celestica is a world leader in the delivery of innovative electronics manufacturing services (EMS). With 2001 revenues in excess of US$10 billion, Celestica is a global operator of a highly sophisticated manufacturing network, providing a broad range of services to leading OEMs (original equipment manufacturers) in the information technology and communications industries. Unrivalled in quality, technology and supply chain management, Celestica provides competitive advantage to its customers by improving time-to-market, scalability and manufacturing efficiency. Celestica has more than 40,000 employees in over 40 locations in the Americas, Europe and Asia. For further information on Celestica, visit its Web site at www.celestica.com. ------------------ The company's security filings can also be accessed at www.sedar.com and ------------- www.sec.gov. MORE... -2- SAFE HARBOUR AND FAIR DISCLOSURE STATEMENT STATEMENTS CONTAINED IN THIS PRESS RELEASE WHICH ARE NOT HISTORICAL FACTS ARE FORWARD-LOOKING STATEMENTS WHICH INVOLVE RISK AND UNCERTAINTIES WHICH COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM THOSE EXPRESSED IN THE FORWARD-LOOKING STATEMENTS. AMONG THE KEY FACTORS THAT COULD CAUSE SUCH DIFFERENCES ARE: THE LEVEL OF OVERALL GROWTH IN THE ELECTRONICS MANUFACTURING SERVICES (EMS) INDUSTRY; LOWER-THAN-EXPECTED CUSTOMER DEMAND; COMPONENT CONSTRAINTS; VARIABILITY OF OPERATING RESULTS AMONG PERIODS; DEPENDENCE ON THE COMPUTER AND COMMUNICATIONS INDUSTRIES; DEPENDENCE ON A LIMITED NUMBER OF CUSTOMERS; AND THE ABILITY TO MANAGE EXPANSION, CONSOLIDATION AND THE INTEGRATION OF ACQUIRED BUSINESSES. THESE AND OTHER FACTORS ARE DISCUSSED IN THE COMPANY'S VARIOUS PUBLIC FILINGS AT www.sedar.com AND http://www.sec.gov. As of its date, this press release contains all material information associated with this event. -30- For further information please contact: Laurie Flanagan Paul Carpino Celestica Corporate Communications Celestica Investor Relations (416) 448-2200 (416) 448-2211 media@celestica.com clsir@celestica.com - ------------------- -------------------
The information that you are accessing on this website may include forward-looking statements related to our future growth, trends in our industry, our financial and operational results and performance that are based on current expectations, forecast and assumptions involving risk and uncertainties that could cause actual outcomes and results to differ materially.
Read the full Cautionary Note here